27843968|t|Moxifloxacin-induced acute psychosis: A case report with literature review.
27843968|a|Third generation quinolones are extensively used to treat a variety of common bacterial infections. Due to their extensive use in clinical practice, an increase in neuropsychiatric events has been reported. We report the case of psychotic symptoms occurs after three doses of moxifloxacin in a healthy adult male with no underlying risk factors. After the discontinuation of moxifloxacin treatment, there was a complete resolution of patient's symptoms. The case draws attention to a rare side effect of a commonly use drug and alert the clinicians to be cautious in those patients that have a baseline risk factors which makes the patient more susceptible to such adverse drug effect.
27843968	0	12	Moxifloxacin	Chemical	MESH:D000077266
27843968	21	36	acute psychosis	Disease	MESH:D011605
27843968	93	103	quinolones	Chemical	MESH:D015363
27843968	154	174	bacterial infections	Disease	MESH:D001424
27843968	240	263	neuropsychiatric events	Disease	MESH:D002318
27843968	305	323	psychotic symptoms	Disease	MESH:D011618
27843968	352	364	moxifloxacin	Chemical	MESH:D000077266
27843968	451	463	moxifloxacin	Chemical	MESH:D000077266
27843968	510	517	patient	Species	9606
27843968	649	657	patients	Species	9606
27843968	708	715	patient	Species	9606
27843968	Negative_Correlation	MESH:D015363	MESH:D001424
27843968	Positive_Correlation	MESH:D000077266	MESH:D011618
27843968	Positive_Correlation	MESH:D000077266	MESH:D002318
27843968	Positive_Correlation	MESH:D000077266	MESH:D011605
27843968	Positive_Correlation	MESH:D015363	MESH:D002318

